Hot products: CYTOSINE,CYTIDINE,URIDINE,DEOXY URIDINE
Small Nucleic Acid Drugs: Second Evolution
New Medicine 3.0
Three years interrupted by the pandemic
The next gold mine to be mined
We will be present at CPHI China – Int. Exhibition for Fine & Speciality Chemicals on 19-21th June in Shanghai . If you want to set up a meeting please do not hesitate to contact our sales.
Potential Release in Nucleic acid drugs—China has become the worlds’ largest exporter of Nucleotide raw materials
Yunbio is one of the manufacturer
The ethylene cracking furnace of Yangtze Petrochemical olefine plant of China Petrochemical Corporation caught fire just now!
Driven by environmental protection and food safety, the global bio-pesticide market is facing unprecedented development opportunities.
We wanted to refresh our Logo, to simplify, and to have a cleaner, more modern look while keeping the feel of the long standing and history
Recently, Science Media GEN spoke with Professor Robert Langer of the David H.Koch Institute at MIT about the present and future of mRNA vaccines as Moderna’s co-founder.
Small molecules have been used in drug discovery historically. How will small molecules continue to meet patient needs in the future? In this review, we take the opportunity to review and clarify some of the historical cornerstones of small molecule drug research, discuss current and future trends in drug discovery, and present a personal vision for the future of drug research, with an emphasis on small molecule drug research…
Recently, The clinical results of Molnupiravir (MK-4482, EIDD-2801), a novel coronavirus small molecule developed by Merk, are relatively exciting. Here is a focus for a
Last year, Moderna quickly developed a candidate vaccine based on mRNA technology after the releasing of the Novel Coronavirus genome sequence by Chinese scientists. It made mRNA technology an overnight success.
We will contact you within 1 working day, please pay attention to the email with the suffix “@yunbiopharm.com”.
